Sanofi Company Profile (NYSE:SNY)

About Sanofi

Sanofi logoSanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products. The emerging markets platform includes products from all three of the Company's principal activities. Under the Company's Pharmaceuticals business, products are grouped into the key fields of diabetes solutions, rare diseases, multiple sclerosis, oncology, thrombosis and cardiovascular disease prevention, nephrology and bio-surgery. The Human Vaccines activity is operated through Sanofi Pasteur. The Animal Health activity is carried out through Merial.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: SNY
  • CUSIP:
Key Metrics:
  • Previous Close: $38.78
  • 50 Day Moving Average: $40.74
  • 200 Day Moving Average: $40.69
  • 52-Week Range: $37.41 - $51.88
  • Trailing P/E Ratio: 21.02
  • Foreward P/E Ratio: 12.82
  • P/E Growth: 1.97
  • Market Cap: $98.71B
  • Outstanding Shares: 2,574,011,000
  • Beta: 0.99
Additional Links:
Companies Related to Sanofi:

Analyst Ratings

Consensus Ratings for Sanofi (NYSE:SNY) (?)
Ratings Breakdown: 3 Sell Ratings, 6 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $65.33 (69.83% upside)

Analysts' Ratings History for Sanofi (NYSE:SNY)
DateFirmActionRatingPrice TargetDetails
8/15/2016Berenberg BankReiterated RatingHold$93.00View Rating Details
6/28/2016Citigroup Inc.Reiterated RatingNeutralView Rating Details
5/12/2016Barclays PLCUpgradeEqual Weight -> OverweightView Rating Details
5/3/2016HSBCDowngradeBuy -> HoldView Rating Details
5/3/2016Bank of America Corp.Reiterated RatingBuy$58.00View Rating Details
4/25/2016JPMorgan Chase & Co.Reiterated RatingSellView Rating Details
4/12/2016Chardan CapitalReiterated RatingBuyView Rating Details
3/18/2016Goldman Sachs Group Inc.Reiterated RatingNeutralView Rating Details
2/10/2016Sanford C. BernsteinLower Price TargetMarket-Perform$52.00 -> $45.00View Rating Details
12/16/2015Oddo SecuritiesDowngradeReduceView Rating Details
12/10/2015BNP ParibasDowngradeNeutral -> UnderperformView Rating Details
12/1/2015Morgan StanleyDowngradeOverweight -> Equal WeightView Rating Details
11/9/2015Bryan, Garnier & CoReiterated RatingBuy -> NeutralView Rating Details
9/16/2015Sarasin & PartnersUpgradeBuyView Rating Details
7/13/2015Deutsche Bank AGUpgradeBuyView Rating Details
4/15/2015Societe GeneraleInitiated CoverageBuyView Rating Details
3/17/2015Leerink SwannUpgradeMarket Perform -> OutperformView Rating Details
1/23/2015Kepler Capital MarketsDowngradeHoldView Rating Details
10/29/2014Jefferies GroupDowngradeBuy -> HoldView Rating Details
10/15/2014Credit Suisse Group AGUpgradeNeutral -> OutperformView Rating Details
(Data available from 9/1/2014 forward)


Earnings History for Sanofi (NYSE:SNY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/29/2015Q315$0.88$0.89ViewN/AView Earnings Details
4/30/2015Q115$0.61$0.73ViewN/AView Earnings Details
2/5/2015Q4$0.89$0.79ViewN/AView Earnings Details
7/31/2014Q2$0.79$0.72ViewN/AView Earnings Details
4/29/2014Q114$0.84$0.81ViewN/AView Earnings Details
2/6/2014Q4$0.88$0.93ViewN/AView Earnings Details
10/30/2013$1.01$0.93ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Sanofi (NYSE:SNY)
Current Year EPS Consensus Estimate: $3.05 EPS
Next Year EPS Consensus Estimate: $3.00 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.65$0.72$0.69
Q2 20162$0.72$0.75$0.74
Q3 20161$0.90$0.90$0.90
Q4 20161$0.65$0.65$0.65
(Data provided by Zacks Investment Research)


Current Dividend Information for Sanofi (NYSE:SNY)
Annual Dividend:$1.12
Dividend Yield:2.91%
Dividend Growth:-1.60% (3 Year Average)
Payout Ratio:61.88% (Based on Trailing 12 Months of Earnings)
36.72% (Based on Current Year Consensus EPS Estimate)
37.33% (Based on Next Year Consensus EPS Estimate)

Dividend History for Sanofi (NYSE:SNY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Sanofi (NYSE:SNY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/9/2014SanofiMajor ShareholderBuy195,000$308.27$60,112,650.00View SEC Filing  
7/8/2014SanofiMajor ShareholderBuy153,000$311.67$47,685,510.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Sanofi (NYSE:SNY)
DateHeadline logoRegeneron’s Growth Opportunities: Praluent, Sarilumab, and Dupilumab (NYSE:SNY) - August 31 at 12:47 PM logoWhy Pfizer’s Valuation Is Suffering (NYSE:SNY) - August 31 at 12:47 PM logoMedivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal (NYSE:SNY) - August 31 at 12:47 PM
News IconHow has Sanofi:(NYSE:SNY) performed recently? - The Daily Leicester (NYSE:SNY) - August 30 at 7:19 PM
News IconInovio kicks off its second Zika vax trial (NYSE:SNY) - August 30 at 10:45 AM logoIncremental Gains For PCSK9s (NYSE:SNY) - August 30 at 10:45 AM logoSpotlight (STLT) to Help Fund Breakthrough Drug Research (NYSE:SNY) - August 30 at 10:44 AM
News IconFocusing on Dividend Stock With Upside Possibility: Sanofi (NYSE:SNY) - Post News (NYSE:SNY) - August 29 at 7:22 PM logoRegeneron (REGN), Sanofi (SNY) Announce Significant Results from Praluent Phase 3 in HeFH Patients - (NYSE:SNY) - August 29 at 7:22 PM logoRegeneron, Sanofi Report Positive Data For Praluent - Quick Facts (NYSE:SNY) - August 29 at 12:00 PM logoWhat’s the Story behind the Pfizer-Medivation Deal? (NYSE:SNY) - August 29 at 12:00 PM logoLate-stage study shows Sanofi/Regeneron's Praluent delivers substantial treatment benefit in patients with inherited high cholesterol (NYSE:SNY) - August 29 at 12:00 PM logoRegeneron (REGN), Sanofi (SNY) Announce Significant Results from Praluent Phase 3 in HeFH Patients (NYSE:SNY) - August 29 at 12:00 PM
News IconLeading stocks in today’s market: Sanofi (NYSE:SNY) (NYSE:SNY) - August 27 at 11:34 AM logoWeek In Review: 'Strengthened' Yellen, Mylan EpiPen Furor, Best Buy Hot, Dollar Stores Pinched (NYSE:SNY) - August 26 at 7:06 PM
News IconUpcoming Earnings Report: Sanofi (NYSE:SNY) - The Voice Registrar (NYSE:SNY) - August 26 at 10:25 AM logoSanofi Just Can't Catch a Break, Knocking at Major Support Again - 24/7 Wall St. (NYSE:SNY) - August 26 at 10:25 AM
News IconSanofi Just Can’t Catch a Break, Knocking at Major Support Again (NYSE:SNY) - August 26 at 8:24 AM logoTone-Deaf Mylan Provides Election-Year Fodder (NYSE:SNY) - August 25 at 7:44 PM
News IconSoaring insulin prices have diabetics feeling the pain (NYSE:SNY) - August 25 at 12:35 PM
News IconFDA request delays timeline for Sanofi’s iGlarLixi drug-device combo for diabetes (NYSE:SNY) - August 25 at 12:35 PM
News IconAll the skinny on Mylan's EpiPen: Price hikes, CEO pay, aggressive ads and more (NYSE:SNY) - August 24 at 7:11 PM
News IconSanofi (NYSE:SNY) from Drug Manufacturers – Major – Todays Top Gains (NYSE:SNY) - August 24 at 7:11 PM logoSanofi Becomes Oversold (NYSE:SNY) - August 24 at 12:37 PM logoSanofi SA (NYSE:SNY) Suffers Setback Following Delay By FDA - Market Exclusive (NYSE:SNY) - August 23 at 7:38 PM
News IconStocks in Mix Momentum- Sanofi (NYSE:SNY), TerraForm Power (NASDAQ:TERP), The Travelers Companies (NYSE ... - Seneca Globe (NYSE:SNY) - August 22 at 12:04 PM
News IconActive Watchful Movers- The Estee Lauder Companies (NYSE:EL), Sanofi (NYSE:SNY), Microsoft (NASDAQ:MSFT) - Seneca Globe (NYSE:SNY) - August 22 at 12:04 PM
News IconSanofi's (SNY): Trader's Focus - Hot Stocks Point (NYSE:SNY) - August 22 at 12:04 PM logoFDA's Sanofi SA (ADR) (NYSE:SNY) Delay Highlights Some Red Flags With IGlarLixi - Market Exclusive (NYSE:SNY) - August 22 at 12:04 PM logoFDA’s Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi (NYSE:SNY) - August 22 at 12:04 PM logoBiotech stocks rally as investors bet on the next big tie-up (NYSE:SNY) - August 22 at 12:04 PM logoPfizer boosts cancer drug roster with $14 billion Medivation deal (NYSE:SNY) - August 22 at 12:04 PM
News IconFDA delays decision on Sanofi, Zealand’s diabetes drug, handing lead to Novo Nordisk (NYSE:SNY) - August 21 at 11:24 AM
News IconIs Sanofi(NYSE: SNY), a large market cap stock a smart buy? - The Daily Leicester (NYSE:SNY) - August 20 at 11:29 AM
News IconDrug Manufacturers – Major: Sanofi (NYSE:SNY) Position of the day (NYSE:SNY) - August 19 at 7:23 PM logo5:03 pm Sanofi provides update on NDA for Investigational once-daily fixed-ratio combination of insulin glargine and Lixisenatide for treatment of adults with type 2 diabetes; PDUFA extended 3 months to Nov 2016 (NYSE:SNY) - August 19 at 7:23 PM logoSanofi Provides Update on New Drug Application for Investigational Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide ​ (NYSE:SNY) - August 19 at 7:23 PM
News IconMedivation up again as Merck now named as latest Big Pharma suitor (NYSE:SNY) - August 18 at 10:35 AM logoMerck joins list of Medivation suitors (NYSE:SNY) - August 17 at 7:52 PM
News IconCSL works on flu vax turnaround as ex-Novartis biz a drag on 2016 profit (NYSE:SNY) - August 17 at 7:52 PM logoMerck Among Companies Looking To Buy Medivation, Says Report (NYSE:SNY) - August 17 at 7:52 PM
News IconLarge Cap Drug Manufacturers – Major: Sanofi (NYSE:SNY) (NYSE:SNY) - August 17 at 7:52 PM
News IconMannKind turns to digital, social media to spread the word on Afrezza's relaunch (NYSE:SNY) - August 16 at 7:37 PM logoSanofi (SNY): Berenberg Expects 2017 To Be A Tough Year For Diabetes (NYSE:SNY) - August 16 at 7:37 PM
News IconTop Gainers of the Day: Sanofi (NYSE:SNY) from Drug Manufacturers – Major (NYSE:SNY) - August 16 at 7:37 PM
News IconWESCO International, (NYSE:WCC) & Sanofi SA (NYSE:SNY ... - Money News (press release) (NYSE:SNY) - August 15 at 7:53 PM logoSanofi (SNY): Berenberg Expects 2017 To Be A Tough Year For Diabetes - (NYSE:SNY) - August 15 at 9:40 AM
News IconToday's Top Gainers in the Market Sanofi (NYSE:SNY) from ... - The Daily Leicester (NYSE:SNY) - August 14 at 11:50 AM
News IconZealand takes PhII data to FDA after pitting diabetes drug against Novo’s incumbent (NYSE:SNY) - August 12 at 10:44 AM logoSanofi-Aventis Set to Possibly Rebound After Yesterday's Selloff of 1.65% (NYSE:SNY) - August 11 at 8:04 PM


Sanofi (NYSE:SNY) Chart for Thursday, September, 1, 2016

Last Updated on 9/1/2016 by Staff